SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PAHC

Phibro Animal Health Corp (NASDAQ:PAHC)

US · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
$33.29-$0.79 (-2.32%)
 
Market cap
$1.35B
Insider Score
Health Score
Analyst consensus
Listed since
Apr 11, 2014
Website
Market Cap$1.35B-22.7%
Revenue (ttm)$1.54B+10.1%
Net Income$102.71M+51.5%
EPS$2.51+51.2%
Shares Out40.60M
PE Ratio13.11
Forward PE8.58
Dividend$0.48(1.44%)
Ex-Dividend DateNov 25, 2026
Volume155,543
Open$34.01
Previous Close$34.08
Day's Range$33.24 - $34.54
52-Week Range$28.25 - $60.08
Beta0.42
AnalystsBuy
Price Target$49.00(+47.19%)
Earnings DateFeb 3, 2027

About PAHC

Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro develops, manufactures, and markets products tailored for various food-producing animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its Animal Health offerings encompass a broad range of pharmaceutical and biological products. These include antimicrobials (both chemical and biological agents) designed to prevent and treat bacterial ailments; anticoccidials, primarily used to control and prevent coccidiosis in poultry and cattle; anthelmintics for combating parasitic intestinal worm infestations; and specific anti-bloat treatments for cattle grazing on legume or wheat pastures. Additionally, the company provides specialized nutritional supplements engineered to enhance animal health and performance, alongside vaccines predominantly for the poultry and swine industries to protect against diseases. The Mineral Nutrition segment focuses on the creation and distribution of various trace mineral formulations and concentrates, featuring elements such as zinc, manganese, copper, iron, and other vital compounds. Furthermore, under its Performance Products segment, Phibro supplies an assortment of specialty ingredients that find application in diverse industries, including personal care, industrial chemicals, and chemical catalysts. Phibro's animal health and mineral nutrition products reach customers through a multi-channel distribution network, including its own local sales offices, direct sales to integrated poultry, swine, and cattle operations, and through commercial animal feed producers, wholesalers, and distributors. The company boasts an extensive international presence, conducting business across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region. Initially known as Philipp Brothers Chemicals, Inc., the company adopted the name Phibro Animal Health Corporation in July 2003. It was officially incorporated in 2014 and maintains its corporate headquarters in Teaneck, New Jersey.

Address
Glenpointe Centre East, Teaneck, NJ, 07666-6712, US
Market Cap
1.35 billion
Employees
2,605
Industrial Classification
Drug Manufacturers - Specialty & Generic

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$2.15M
Bought
$317.70K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Sound
From PAHC’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-2.32%
5 Days
-7.63%
1 Month
-16.38%
6 Months
+0.09%
1 Year
-22.73%

$PAHC stock is featured in our Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of PAHC by members of U.S. Congress

Michael T. McCaulHouse / RSale$1.00K – $15.00KSep 1, 2022
Michael T. McCaulHouse / RSale$1.00K – $15.00KAug 30, 2022
Michael T. McCaulHouse / RSale$1.00K – $15.00KMar 4, 2022
Michael T. McCaulHouse / RSale$1.00K – $15.00KMar 2, 2022
Michael T. McCaulHouse / RSale$1.00K – $15.00KDec 14, 2021
Michael T. McCaulHouse / RPurchase$1.00K – $15.00KMar 4, 2021

Recently reported changes in PAHC holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by PAHC's directors and management

Net Shares Purchased by Insiders−30k−15k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

PAHC Estimated quarterly lobbying spending

Source: U.S. Senate LDA

PAHC Revenue by Segment or Geography

$386.77MTotal
Animal Health$293.05M75.77%
Mineral Nutrition$73.56M19.02%
Performance Products$20.16M5.21%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New PAHC patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to PAHC from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in PAHC

IJRiShares Core S&P Small-Cap ETF$42.27M
VTIVanguard Morningstar Total Stock Market ETF$21.02M
IWMiShares Russell 2000 ETF$19.30M
VXFVanguard Extended Market ETF$9.37M
IWOiShares Russell 2000 Growth ETF$6.90M
SPSMState Street SPDR Portfolio S&P 600 Small Cap ETF$6.53M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from PAHC’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
13.78
Analyst Ratings
32% of score
60
News & Sentiment
20% of score
72

News check: Phibro coverage shows positive momentum with revenue beats, favorable valuation narratives, and analyst engagement, though language remains measured and guidance-focused.

Recent Insider Activity

Buys
1
Sells
14
Buy Value
$317.70K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

FDMFirst Trust Dow Jones Select MicroCap Index Fund1.23%
XPHState Street SPDR S&P Pharmaceuticals ETF1.16%
GRPZInvesco S&P SmallCap 600 GARP ETF0.92%
RZGInvesco S&P SmallCap 600 Revenue ETF0.91%
AIMSAcuitas Small Cap Active ETF0.59%
SMIZZacks Small/Mid Cap ETF0.51%
ROSCHartford Multifactor Small Cap ETF0.48%
LITLSimplify Piper Sandler US Small-Cap PLUS Income ETF0.48%
HAPSHarbor Human Capital Factor US Small Cap ETF0.43%
PSCHInvesco S&P SmallCap Health Care ETF0.39%
SYZLazard US Systematic Small Cap Equity ETF0.34%
BFORALPS ETF Trust - Barron's 400 ETF0.25%

Weight is the stock’s share of each fund’s holdings.